{{chembox
| ImageFile = Inogatran.svg
| ImageSize = 275px
| ImageAlt =
| IUPACName = 2-<nowiki/>{[(2''R'')-1-[(2''S'')-2-[(4-Carbamimidamidopropyl)carbamoyl]piperidin-1-yl]-3-cyclohexyl-1-oxopropan-2-yl]amino}acetic acid
| OtherNames = ''N''-[(1''R'')-2-Cyclohexyl-1-<nowiki>[[</nowiki>(2''S'')-2-[(3-guanidinopropyl)carbamoyl]piperidino]carbonyl]<br />ethyl]glycine

| Section1 = {{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 428409I84L
| CASNo = 155415-08-0
| PubChem = 66005
| ChEMBL = 114715
| ChemSpiderID = 59397
| StdInChI = 1S/C21H38N6O4/c22-21(23)25-11-6-10-24-19(30)17-9-4-5-12-27(17)20(31)16(26-14-18(28)29)13-15-7-2-1-3-8-15/h15-17,26H,1-14H2,(H,24,30)(H,28,29)(H4,22,23,25)/t16-,17+/m1/s1
| StdInChIKey = CDPROXZBMHOBTQ-SJORKVTESA-N
| SMILES = NC(=N)NCCCNC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC2CCCCC2)NCC(=O)O
  }}

| Section2 = {{Chembox Properties
| Formula = C<sub>21</sub>H<sub>38</sub>N<sub>6</sub>O<sub>4</sub>
| MolarMass = 438.6 g/mol
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
| Solubility =
  }}

| Section3 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
}}

'''Inogatran''' ([[International nonproprietary name|INN]])<ref name="INN">{{cite web | title = International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 35 | url = http://www.who.int/medicines/publications/druginformation/innlists/RL35.pdf | publisher = World Health Organization | accessdate = 2 December 2016 | page = 13}}</ref> is a low [[molecular weight]] peptidomimetic [[Direct thrombin inhibitor|thrombin inhibitor]]. Inogatran was developed for the potential treatment of [[Artery|arterial]] and [[Vein|venous]] [[Thrombosis|thrombotic]] diseases.<ref>{{cite journal | last1 = Teger-Nilsson | first1 = AC | last2 = Bylund | first2 = R | last3 = Gustafsson | first3 = D | last4 = Gyzander | first4 = E | last5 = Eriksson | first5 = U | title = ''In Vitro'' Effects of Inogatran, a Selective Low Molecular Weight Thrombin Inhibitor | journal = [[Thrombosis Research]] | date = January 1997 | volume = 85 | issue = 2 | pages = 133â€“45 | doi = 10.1016/s0049-3848(96)00230-7 | pmid = 9058487}}</ref>

==References==
{{reflist}}

{{Antithrombotics}}

[[Category:Direct thrombin inhibitors]]
[[Category:Guanidines]]


{{blood-drug-stub}}